T
Thirty Madison
Thirty Madison is a family of specialized healthcare brands creating exceptional outcomes for all
About Thirty Madison
A virtual-first healthcare company that provides specialized care for people with chronic conditions. Thirty Madison has built a portfolio of brands, including Keeps for men's hair loss, Cove for migraine, Facet for skin conditions, and Nurx for women's health. The company's business model is centered on a direct-to-consumer approach, offering online consultations with healthcare providers, personalized treatment plans, and home delivery of medications and products. This model aims to improve access to care and make it more affordable and convenient for patients.
Thirty Madison generates revenue by selling its specialized healthcare services and products. Patients typically pay for consultations and subscribe to receive regular shipments of their prescribed treatments. The company has a significant user base, with over 750,000 active patients, and has established itself as a key player in the telehealth market. By focusing on specific chronic conditions, Thirty Madison is able to provide targeted and effective care, which has resonated with consumers looking for more specialized healthcare solutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- New York City, United States
- Employees
- 208
- Open positions
- 4
- Dealroom signal
- 62.0/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Tech for Biotech and Pharma, Tech for Patients, From Unicorn to Zebra (But No $1B Exit)
- Client focus
- b2c
- Investment activity
- 1 company, latest Feb 2022
- Capital deployed
- —
- Preferred round
- MERGER
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2025 | $500M | $500M | Remedy Meds | ↗ |
| SECONDARYOther financing | Apr 2024 | $1.3M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Thirty Madison is 6.1K monthly website visits, down 15.3% over the last three months. Thirty Madison's team declined 31.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
NURXSan Francisco, United StatesTelemedicine platform focused on birth control and HIV prevention
$268Mvaluation
CoveNew York City, United StatesPrescription Medication for Migraine Relief | Cove
→
KeepsNew York City, United StatesHealth-care company focused on male pattern baldness prevention and treatment
$61Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Series A3 investors entered at this stage
Northzone
Polaris Partners
Johnson & Johnson Innovation
Series B and later3 investors entered at this stage
HealthQuest Capital
Mousse Partners
Bracket Capital
Other known investors2 additional known investors
- NURX
Remedy Meds
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Thirty Madison on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Thirty Madison’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.